Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alkermes (ALKS) Total Liabilities (2016 - 2025)

Alkermes (ALKS) has disclosed Total Liabilities for 16 consecutive years, with $667.7 million as the latest value for Q4 2025.

  • Quarterly Total Liabilities rose 13.06% to $667.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $667.7 million through Dec 2025, up 13.06% year-over-year, with the annual reading at $667.7 million for FY2025, 13.06% up from the prior year.
  • Total Liabilities for Q4 2025 was $667.7 million at Alkermes, up from $596.1 million in the prior quarter.
  • The five-year high for Total Liabilities was $933.5 million in Q4 2023, with the low at $570.4 million in Q1 2025.
  • Average Total Liabilities over 5 years is $823.2 million, with a median of $887.1 million recorded in 2022.
  • The sharpest move saw Total Liabilities grew 13.48% in 2021, then crashed 36.74% in 2024.
  • Over 5 years, Total Liabilities stood at $911.9 million in 2021, then rose by 0.91% to $920.2 million in 2022, then rose by 1.45% to $933.5 million in 2023, then tumbled by 36.74% to $590.6 million in 2024, then increased by 13.06% to $667.7 million in 2025.
  • According to Business Quant data, Total Liabilities over the past three periods came in at $667.7 million, $596.1 million, and $628.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.